National Research Corp

National Research Corp. engages in the provision of analytics and insights that facilitate patient, employee, and customer retention. It offers solutions that address specific needs around market insight, experience, transparency, and governance for healthcare providers, payers, and other healthcare organizations. The company was founded by Michael D. Hays in 1981 and is headquartered in Lincoln, NE.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

NRC Health reports mixed Q4 2022 results amidst growth opportunities

NRC Health faced challenges in operating income and tax rates in Q4 2022 but demonstrated strength in core offering growth and client relationships.
The company's focus on humanized healthcare and capital allocation for innovation present opportunities for future growth and competitiveness.
Strategic adjustments post the Canadian location closure and efficient capital expenditure management will be key to overcoming challenges and seizing opportunities.
Overall, NRC Health's performance in Q4 2022 reflects a mix of challenges, strengths, and opportunities that will shape its future trajectory in the healthcare industry.

NRC Health reports Q1 revenue decline, focuses on healthcare humanization

NRC Health faced revenue and operating income declines in Q1 2023, attributed to a location closure and increased marketing expenses.
Despite challenges, the company's recognition as a top workplace and clear capital allocation priorities showcase strengths and strategic focus.
Opportunities lie in leveraging healthcare humanization and patient insights for future growth and exploring new markets for revenue diversification.

National Research Corp reports sales surge amidst revenue decline

NRC's Q2 2023 earnings call highlighted mixed financial performance with strong sales growth but revenue and income declines. The company's strategic focus on the Human Understanding Program and cost alignment presents opportunities for future growth and efficiency.

National Research Corp (NRC) reports mixed Q3 results, eyes growth opportunities

National Research Corp (NRC) navigated Q3 2023 with a focus on revenue growth acceleration and margin expansion. Despite challenges in operating income, the company's strategic initiatives and strong balance sheet position it well for future growth opportunities.

National Research Corp (NRC) reports mixed Q4 results, eyes growth opportunities

National Research Corp (NRC) navigated mixed financial results in Q4 2023, with a focus on strategic realignment to meet client demands and achieve growth. While facing challenges such as revenue decline and profitability pressures, the company remains committed to innovation and long-term sustainability. Future opportunities lie in expanding market reach, launching new products, and enhancing operational efficiency.

National Research Corp (NRC) posts solid Q1 results, eyes tech-driven growth

National Research Corp (NRC) reported solid Q1 2024 performance, focusing on technology-driven healthcare insights and strategic initiatives to drive growth and value creation for investors.
The company's emphasis on innovation, expanding the total addressable market, and enhancing client interactions underscores their commitment to delivering actionable insights and sustainable financial results.
With a strong financial foundation, NRC is well-positioned to navigate challenges, capitalize on opportunities, and drive continued growth through investments in technology, sales, and product development.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Discover why Zacks has given NRC Health a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Dive into the company's AI innovations, strategic partnerships, and financial resilience, along with the challenges of revenue declines, rising debt and stiff competition.

Zacks Initiates Coverage of NRC Health With Neutral Recommendation

LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareInnovation--Signature Healthcare has selected NRC Health to enhance its network through human-centered healthcare solutions and data-driven insights.

Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $35.8 million compared with approximately $37.9 million in the 2023 quarter. Earnings per diluted share were $0.24 compared with $0.32 for the 2023 quarter. At September 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) w.

National Research Corporation Announces Third Quarter Results

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2024 and several other corporate developments. Financial Results Revenue for the quarter was approximately $35 million compared with approximately $36 million in the 2023 quarter. Earnings per diluted share were $0.26 compared with $0.29 for the 2023 quarter. At June 30, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) w.

National Research Corporation Announces Second Quarter Results

Castle Biosciences Inc

Owens & Minor

Pacira Pharmaceuticals

Cassava Sciences Inc

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks That May Explode In July

National Research Corporation [NRC] Q1 2024 Earnings Conference Call May 8, 2024 11:00 AM ET Company Participants Linda Stacy - VP, Finance Mark Scudder - ELT Helen Hrdy - CCO Operator Good morning or good afternoon all, and welcome to the National Research Corporation First quarter earnings call. My name is Adam, and I'll be your operator today.

National Research Corporation (NRC) Q1 2024 Earnings Call Transcript

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2024. CEO Commentary Michael Hays, Chief Executive Officer, commented: “NRC continues to be strongly positioned for growth in our expanding markets. Our decades of benchmarks and trusted thought leadership afford healthcare insights unavailable to most competitors, while our client service remains unmatched, and we continue to roll out innovative new products.

National Research Corporation Announces First Quarter Results

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company's results for the 2024 first quarter will be released after the close of the market on Tuesday, May 7, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on May 8, 2024. A 30-day online replay will be available.

National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet

LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareInnovation--NRC Health, a recognized leader providing solutions and data driven insights for improving health care experiences, announced today the appointment of Jennifer Baron as the organization's first chief experience officer. Baron's addition is part of the organization's continued investments in leadership and innovation to align with the evolving healthcare landscape. In this newly created role, Baron will lead NRC Health's experience strategy, sustaining and advanci.

Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

National Research Corporation (NRC) Q4 2023 Earnings Call Transcript

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023. CEO Commentary Michael Hays, Chief Executive Officer, commented: “We're pleased to start 2024 with momentum from another consecutive quarter of growth in new sales and operating margin. We have trimmed non-core service lines, and developed our capability across the patient, customer, and employee experience continuum to focus on our clients' most impor.

National Research Corporation Announces Fourth Quarter and Calendar Year 2023 Results

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2023 fourth quarter and year-end earnings conference call on Wednesday, February 14, 2024. The Company's results for the 2023 fourth quarter will be released after the close of the market on Tuesday, February 13, 2024. The live broadcast of National Research Corporation's conference call will begin at 11:00 a.m. Eastern Time on February 14, 2024. A 30-da.

National Research Corporation to Broadcast Its Fourth Quarter and Year-end 2023 Conference Call Live on the Internet

LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) has announced the following appointments of four newly created executive officer positions: Helen Hrdy – Chief Customer Officer Jason Hahn – Chief Revenue Officer Christophe Louvion – Chief Product Technology Officer Andy Monnich – Chief Corporate Development Officer Helen Hrdy, a leader at NRC Health, has been promoted to the role of Chief Customer Officer significantly expanding her responsibilities. J.

National Research Corporation Elevates Leadership Team to Seize Growth Opportunity

Lincoln, Nebraska, Nov. 17, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, January 12, 2024, to shareholders of record as of the close of business on Friday, December 29, 2023.

National Research Corporation Declares Quarterly Dividend

National Research Corporation (NASDAQ:NRC ) Q3 2023 Results Conference Call November 8, 2023 11:00 AM ET Company Participants Kevin Karas - CFO Linda Stacy - VP, Finance Conference Call Participants Operator Hello, everyone, and welcome to the National Research Corporation Third Quarter 2023 Earnings Call. My name is Charlie and I'll be coordinating the call today.

National Research Corporation (NRC) Q3 2023 Earnings Call Transcript

LINCOLN, Neb., Nov. 07, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the third quarter 2023.

National Research Corporation Announces Third Quarter 2023 Results

Lincoln, Nebraska, Oct. 24, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 third quarter earnings conference call on Wednesday, November 8, 2023. The Company's results for the 2023 third quarter will be released after the close of the market on Tuesday, November 7, 2023.

National Research Corporation to Broadcast its 2023 Third Quarter Conference Call Live on the Internet

LINCOLN, Neb., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NRC Health is pleased to announce that Lurie Children's Hospital of Chicago has expanded their long-time partnership to include NRC Health's Market Insights, the nation's most comprehensive and longest-running syndicated study of consumer perceptions in healthcare. As a valued partner utilizing NRC's patient experience technology and expertise, Lurie Children's has expanded their relationship to better understand their patients and the broader communities they serve.

Lurie Children's expands partnership with NRC Health to gain valuable consumer insights

Lincoln, Nebraska, Sept. 06, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) announced that its Board of Directors has declared a special dividend of one dollar ($1.00) per share to shareholders of record as of the close of business on Monday, September 18, 2023, and payable on Friday, September 22, 2023.

National Research Corporation Declares Special Dividend

BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- NRC Health and ICD Media Group have formalized more plans for the upcoming Patient Experience Symposium that's taking place Sept. 18-20, 2023 in Waltham, Massachusetts. The event will provide a dynamic platform for senior-level healthcare executives and practitioners to have discussions on emerging trends and best practices in patient experience. NRC Health's partners can now register until September 15 to receive a 15% discount.

NRC Health emphasizes its commitment to ICD's annual Patient Experience Symposium

LINCOLN, Neb., Aug. 29, 2023 (GLOBE NEWSWIRE) -- LifeBridge Health has selected NRC Health to be its partner in providing Human Understanding® through personalized healthcare solutions and data-driven insights.

LifeBridge Health selects NRC Health as its new patient experience partner

LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health, a leading provider of Human Understanding® and data-driven insights, is pleased to announce the recipients of the 2023 Consumer Loyalty Awards and the Excellence in Patient Experience Awards.

NRC Health unveils winners of 2023 patient experience and loyalty awards

National Research Corporation (NASDAQ:NRC ) Q2 2023 Earnings Conference Call August 2, 2023 11:00 AM ET Company Participants Kevin Karas - Chief Financial Officer Linda Stacy - Vice President, Finance Operator Hello and welcome to today's National Research Corporation Second Quarter 2023 Earnings Call. My name is Bailey and I will be your moderator for today.

National Research Corporation (NRC) Q2 2023 Earnings Call Transcript

LINCOLN, Neb., Aug. 01, 2023 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2023.

National Research Corporation Announces Second Quarter 2023 Results

Lincoln, Nebraska, July 18, 2023 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2023 second quarter earnings conference call on Wednesday, August 2, 2023. The Company's results for the 2023 second quarter will be released after the close of the market on Tuesday, August 1, 2023.

News for National Research Corp Stock (NRC)